Cottage Street Advisors’s Core Laboratories CLB Stock Holding History

Cottage Street Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,600	Closed	-$301K	–	95
2018 Q3	$301K	Hold	2,600	–	–	0.17%	74
2018 Q2	$328K	Sell	2,600 -1,000	-28%	-$122K	0.19%	76
2018 Q1	$390K	Hold	3,600	–	–	0.24%	68
2017 Q4	$394K	Hold	3,600	–	–	0.23%	65
2017 Q3	$355K	Sell	3,600 -255	-7%	-$24.7K	0.23%	66
2017 Q2	$390K	Sell	3,855 -514	-12%	-$55.4K	0.26%	66
2017 Q1	$505K	Sell	4,369 -2,250	-34%	-$261K	0.36%	58
2016 Q4	$795K	Sell	6,619 -2,300	-26%	-$255K	0.61%	53
2016 Q3	$1M	Buy	8,919 +2,050	+30%	+$236K	0.77%	49
2016 Q2	$851K	Sell	6,869 -50	-0.7%	-$6.04K	0.69%	54
2016 Q1	$778K	Sell	6,919 -505	-7%	-$52.5K	0.68%	53
2015 Q4	$864K	Buy	+7,424	New	+$850K	0.76%	48

Other funds holding CLB

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Cottage Street Advisors's CLB Position: Q4 2018 in Review

Cottage Street Advisors sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 2,600 shares — an estimated $301K sold.

Cottage Street Advisors first reported a position in CLB in Q4 2015 and held it in 12 quarters. The position peaked at $1M in Q3 2016. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

Cottage Street Advisors reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
Cottage Street Advisors sold 2,600 Core Laboratories shares in Q4 2018, an estimated $301K.
Cottage Street Advisors first reported a position in Core Laboratories in Q4 2015 and held it in 12 quarters.
Cottage Street Advisors's Core Laboratories position peaked at $1M in Q3 2016.
320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Cottage Street Advisors's 13F filing for Q4 2018, filed 1 Feb 2019.